Refine Results
- Products
-
- Applications and Industries
-
- Content Type
-
Content Type
- Analysis Platform
-
Analysis Platform
- Language
-
Language
Reproducible cell-based assays require consistent maintenance of cell cultures and accurate evaluation of culture characteristics across users and applications. Agilent BioTek automated imaging systems and Gen5 image analysis software support...
Simplify cell image analysis with the Agilent BioTek Gen5 AI cell identification module. AI-based segmentation delivers reliable cell counting and confluence data with less optimization.
BioTek Instruments began manufacturing microplate instrumentation in 1981 and has since evolved into a global leader in life science instrumentation.
ADME is the abbreviation commonly used for the study of how a drug is absorbed, distributed, metabolized, and excreted from the body. Each set of assays is performed as part of the drug discovery process to ensure that a drug is properly absorbed...
TCID50 (50% tissue culture infectious dose) is an endpoint dilution assay used to measure infectious viral titer. This method involves infecting cultured cells within a microplate and is useful for viruses that do not form plaques.
Discover the advantages of 3D cell culture models in biomedical research for accurate disease modeling and drug testing that closely mimics human tissues.
Neurite outgrowth assays provide a means to investigate essential aspects of neuronal function in vitro and advance both fundamental and clinical neuroscience research.
The development of safe and effective therapies requires a deeper understanding of cancer cell biology, enabled by effective cell analysis tools and products for investigating the complex tumor micro-environment.
Gain detailed quantitative insight into 3D immuno-oncology models with Agilent Cell Analysis instruments and application solutions
Explore Agilent analytics, cell analysis, and molecular biology solutions for accelerating drug development with predictive in vitro, new approach methodologies (NAM).